Mena Boules, MD

Ironwood Pharmaceuticals, Inc.

Poster(s):

• P1521 - Safety and Tolerability of Once-Weekly Glucagon-Like Peptide-2 Analog Apraglutide in Patients With Short Bowel Syndrome and Intestinal Failure: Results From a Global, Phase 3, Randomized, Double-Blind Trial
  Sunday, October 27, 2024

  3:30 PM – 7:00 PM ET